Type 1 SMA Babies See Benefit With Novel Drug

]]>(MedPage Today) -- Infants with Type 1 spinal muscular atrophy (SMA) treated with investigational risdiplam for 1 year experienced significant gains in motor function, the FIREFISH Part 2 pivotal trial showed.The global open-label study met its...